The Role of Outpatient Transtelephonic ECG Monitoring and Self-Medication Following Acute Myocardial Infarction

  • Daniel David
  • Elieser Kaplinsky

Abstract

Malignant ventricular arrhythmias associated with the various consequences of myocardial ischemia constitute the major cause of sudden, out-of-hospital death in the western societies. Among these, a significant subset of patients is the group having sustained a myocardial infarction in the past [1–3]. This chapter considers a potential approach to this problem being investigated in post-myocardial infarction patients by providing medical help to the patient at risk before the arrival of emergency medical personnel.

Keywords

Ischemia Propen Syringe Cardiol Hunt 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ruberman W, Weinblatt E, Goldberg JD, Frank CW, Chaudhary BS, Shapiro S: Ventricular premature complexes and sudden death after myo-cardial infarction. Circulation 64: 297–305, 1981.PubMedCrossRefGoogle Scholar
  2. 2.
    The Coronary Drug Project Research Group: Prognostic importance of premature beats following myocardial infarction. JAMA 223: 1116–1124, 1973.CrossRefGoogle Scholar
  3. 3.
    Rappaport E, Remedois P: The high risk patient after recovery from myocardial infarction: Recognition and management. J Am Coll Cardiol 2: 391–400, 1983.CrossRefGoogle Scholar
  4. 4.
    Hasin Y, David D, Rogel S: Diagnostic and therapeutic assessment by telephone electrocardiographic monitoring of ambulatory patients. Br Med J 2: 609–612, 1976.PubMedCrossRefGoogle Scholar
  5. 5.
    Seidell FR, Markis JE, Groff W, Kaminski A: Enhancement of drug absorption after administration by an automatic injector. J Pharmaco-kinet Biopharm 2: 197, 1974.CrossRefGoogle Scholar
  6. 6.
    Bellet S, Roman L, Kostis JB, Fleischmann D: Intramuscular lidocaine in the therapy of ventricular arrhythmias. Am J Cardiol 27: 291–293, 1971.PubMedCrossRefGoogle Scholar
  7. 7.
    Ryden L, Waldenstom A, Ehn L, Holmberg S, Husaini M: Comparison between effectiveness of intramuscular and intravenous lidocaine on ventricular arrhythmias complicating acute myocardial infarction. Br Heart J 35: 1124–1131, 1973.PubMedCrossRefGoogle Scholar
  8. 8.
    Sloman G, Hamer A, Baker G, Hunt D: Use of lignocaine and atropine auto-injection for patients at high risk of sudden death and reinfarction after myocardial infarction. Med J Aust 1 (7) 349–51, 1981.PubMedGoogle Scholar
  9. 9.
    Lie KL, Louridtz WJ, Janse MJ, Willebrands AF, Durrer D: Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after 300 mg intramuscular injection. Am J Cardiol 42: 486–488, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Valantine PA, Frew JL, Mashford ML, Sloman JG: Lidocaine in the prevention of sudden death in the prehospital phase of acute myocardial infarction. N Engl J Med 291: 1327–1331, 1974.CrossRefGoogle Scholar
  11. 11.
    Wennerblom B, Holmberg S, Ryden L, Wedel H: Antiarrhythmic efficacy and side effects of lidocaine given in the prehospital phase of acute myocardial infarction. Eur Heart J 3: 316–524, 1982.Google Scholar
  12. 12.
    Adgey AAJ, GeddesJS, Mulholland HC, Keegan DAJ, Pantridge JF: Incidence, significance, and management of early bradyarrhythmia complicating acute myocardial infarction. Lancet 2: 1097–1101, 1968.PubMedCrossRefGoogle Scholar
  13. 13.
    Chadda KD, Lichtstein E, Gupta PK, Choy R: Bradycardia—hypotension syndrome in acute myocardial infarction: reappraisal of the overdrive effects of atropine. Am J Med 59: 158–163, 1975.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston/Dordrecht/Lancaster 1985

Authors and Affiliations

  • Daniel David
  • Elieser Kaplinsky

There are no affiliations available

Personalised recommendations